Global Embolotherapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Embolotherapy market size will reach 4,898.81 Million USD in 2025 and is projected to reach 7,918.03 Million USD by 2032, with a CAGR of 7.10% (2025-2032). Notably, the China Embolotherapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Embolotherapy is a medical procedure used to treat various conditions by deliberately occluding or blocking blood vessels or arteries. It is typically employed to manage conditions like aneurysms, arteriovenous malformations, and tumors, with the goal of restricting or eliminating blood flow to the affected area. During embolotherapy, embolic agents, such as coils, microspheres, or other materials, are introduced into the targeted blood vessel through catheters. These agents cause blockages that halt blood circulation, preventing the supply of nutrients and oxygen to the abnormal tissue or lesion. Embolotherapy is a minimally invasive alternative to traditional surgery and can result in reduced risks, shorter recovery times, and fewer complications for patients with vascular or oncological conditions.
The major global suppliers of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian, Stryker, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Cook Medical, Meril Life Sciences, Kaneka, Peijia Medical Limited, Wallaby Medical, MicroPort Scientific Corporation, Shandong Visee Medical Devices Co.,Ltd, Beijing Taijie Weiye Technology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Embolotherapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Embolotherapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Embolotherapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Embolotherapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Embolotherapy Include:
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Meril Life Sciences
Kaneka
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Embolotherapy Product Segment Include:
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Embolotherapy Product Application Include:
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Embolotherapy Industry PESTEL Analysis
Chapter 3: Global Embolotherapy Industry Porter's Five Forces Analysis
Chapter 4: Global Embolotherapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Embolotherapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Embolotherapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Embolotherapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Embolotherapy market size will reach 4,898.81 Million USD in 2025 and is projected to reach 7,918.03 Million USD by 2032, with a CAGR of 7.10% (2025-2032). Notably, the China Embolotherapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Embolotherapy is a medical procedure used to treat various conditions by deliberately occluding or blocking blood vessels or arteries. It is typically employed to manage conditions like aneurysms, arteriovenous malformations, and tumors, with the goal of restricting or eliminating blood flow to the affected area. During embolotherapy, embolic agents, such as coils, microspheres, or other materials, are introduced into the targeted blood vessel through catheters. These agents cause blockages that halt blood circulation, preventing the supply of nutrients and oxygen to the abnormal tissue or lesion. Embolotherapy is a minimally invasive alternative to traditional surgery and can result in reduced risks, shorter recovery times, and fewer complications for patients with vascular or oncological conditions.
The major global suppliers of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian, Stryker, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Cook Medical, Meril Life Sciences, Kaneka, Peijia Medical Limited, Wallaby Medical, MicroPort Scientific Corporation, Shandong Visee Medical Devices Co.,Ltd, Beijing Taijie Weiye Technology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Embolotherapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Embolotherapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Embolotherapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Embolotherapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Embolotherapy Include:
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Meril Life Sciences
Kaneka
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Embolotherapy Product Segment Include:
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Embolotherapy Product Application Include:
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Embolotherapy Industry PESTEL Analysis
Chapter 3: Global Embolotherapy Industry Porter's Five Forces Analysis
Chapter 4: Global Embolotherapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Embolotherapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Embolotherapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Embolotherapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Embolotherapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Embolotherapy Product by Type
- 1.2.1 Microspheres for Embolization
- 1.2.2 Embolism Particles
- 1.2.3 Embolic coils
- 1.2.4 Liquid Embolic Agent
- 1.2.5 Auxiliary Embolization Material
- 1.2.6 Others
- 1.3 Embolotherapy Product by Application
- 1.3.1 Cancer
- 1.3.2 Peripheral Aascular Disease
- 1.3.3 Nerve System Disease
- 1.3.4 Others
- 1.4 Global Embolotherapy Market Size Analysis (2020-2032)
- 1.5 Embolotherapy Market Development Status and Trends
- 1.5.1 Embolotherapy Industry Development Status Analysis
- 1.5.2 Embolotherapy Industry Development Trends Analysis
- 2 Embolotherapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Embolotherapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Embolotherapy Market Analysis by Country
- 4.1 Global Embolotherapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Embolotherapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Embolotherapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Embolotherapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Embolotherapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Embolotherapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Embolotherapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Embolotherapy Market Analysis by Type
- 6.1 Global Embolotherapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Embolotherapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Medtronic
- 7.1.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Medtronic Embolotherapy Product Portfolio
- 7.1.3 Medtronic Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Boston Scientific
- 7.2.1 Boston Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Boston Scientific Embolotherapy Product Portfolio
- 7.2.3 Boston Scientific Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Terumo
- 7.3.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Terumo Embolotherapy Product Portfolio
- 7.3.3 Terumo Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Penumbra, Inc.
- 7.4.1 Penumbra, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Penumbra, Inc. Embolotherapy Product Portfolio
- 7.4.3 Penumbra, Inc. Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Johnson & Johnson
- 7.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Johnson & Johnson Embolotherapy Product Portfolio
- 7.5.3 Johnson & Johnson Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sirtex
- 7.6.1 Sirtex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sirtex Embolotherapy Product Portfolio
- 7.6.3 Sirtex Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Merit Medical
- 7.7.1 Merit Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Merit Medical Embolotherapy Product Portfolio
- 7.7.3 Merit Medical Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Varian
- 7.8.1 Varian Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Varian Embolotherapy Product Portfolio
- 7.8.3 Varian Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Stryker
- 7.9.1 Stryker Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Stryker Embolotherapy Product Portfolio
- 7.9.3 Stryker Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
- 7.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
- 7.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Cook Medical
- 7.11.1 Cook Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Cook Medical Embolotherapy Product Portfolio
- 7.11.3 Cook Medical Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Meril Life Sciences
- 7.12.1 Meril Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Meril Life Sciences Embolotherapy Product Portfolio
- 7.12.3 Meril Life Sciences Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Kaneka
- 7.13.1 Kaneka Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Kaneka Embolotherapy Product Portfolio
- 7.13.3 Kaneka Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Peijia Medical Limited
- 7.14.1 Peijia Medical Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Peijia Medical Limited Embolotherapy Product Portfolio
- 7.14.3 Peijia Medical Limited Embolotherapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Wallaby Medical
- 7.15.1 Wallaby Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Wallaby Medical Embolotherapy Product Portfolio
- 7.15.3
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
